| Literature DB >> 28350903 |
Ephraim L Tsalik1,2, Elizabeth Petzold1, Barry N Kreiswirth3, Robert A Bonomo4,5, Ritu Banerjee6, Ebbing Lautenbach7, Scott R Evans8, Kimberly E Hanson9, Jeffrey D Klausner10, Robin Patel11.
Abstract
Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, we provide an overview of that development, highlighting several examples where innovation in study design, content, and execution is advancing the field of infectious diseases diagnostics.Entities:
Keywords: antibacterial resistance; devices.; diagnostics
Mesh:
Substances:
Year: 2017 PMID: 28350903 PMCID: PMC5848376 DOI: 10.1093/cid/ciw831
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079